Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing Radioiodine Treatment in Low Risk Papillary Thyroid Cancer

NCT06271044 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT06271044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06271044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing Radioiodine Treatment in Low Risk Papillary Thyroid Cancer
Lead sponsor
Helsinki University Central Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 31, 2014
Completion date
December 31, 2027
Enrollment
61 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

to omit radioiodine treatment safely in patients with low -risk papillary thyroid cancer with seize of 11-20mm